Dabur India Other Announcement
Dabur India Limited filed its Security Cover Certificate for the quarter ended June 30, 2026, which is reported as 'Not Applicable' for its unsecured debentures.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
70 announcements with these filters
Dabur India Limited filed its Security Cover Certificate for the quarter ended June 30, 2026, which is reported as 'Not Applicable' for its unsecured debentures.
Dabur India reported a 15% surge in consolidated net profit to ₹591 Crore and a 10.6% revenue increase to ₹3,764 Crore for the quarter ending June 2026.
Dabur India announced an internal management restructuring, resulting in three executives ceasing to be categorized as Senior Management Personnel while continuing their roles within the company.
Dabur delivered a robust Q1 FY27 with 10.6% consolidated revenue growth and 15% PAT growth. Management highlighted double-digit gains in HPC and Foods despite high inflation and geopolitical headwinds.
Dabur India reported a 10.6% rise in consolidated revenue to ₹3,764 Crore, with net profit surging 15% to ₹591 Crore for the first quarter.
Dabur India Ltd reported revenue from operations of ₹3,764 Cr (+10.6% YoY) and net profit of ₹586.2 Cr (+15.3% YoY) for Q1 FY27.
Dabur India Limited announces its AGM on August 6, 2026, to adopt financials and declare final dividend of Rs.5.50 per share. Director reappointments and cost auditor ratification are also on agenda.
Dabur India filed its BRSR for FY2025-26 with third-party assurance. The report covers ESG disclosures and operational sites, as mandated by SEBI.
Dabur India filed its Integrated Annual Report 2025-26 and AGM notice. The report highlights sustainability efforts under the theme 'Layer by Layer Towards Net Zero'.
Dabur expects double-digit revenue and profit growth for Q1 FY27. This update precedes the formal financial results to be approved by the Board.
US FDA has issued Import Alert 66-40 on Dabur’s Silvassa plant. The company says the sanction has no financial or operational impact.
US FDA issued an Import Alert on Dabur's Silvassa plant for data integrity lapses. The company says the impact is limited to private label products with insignificant revenue.
Dabur India clarified that USFDA observations at its Silvassa plant concern a small, low-revenue segment. The facility remains operational while the company implements corrective actions.
Dabur India allotted 2,62,216 equity shares following employee stock option exercises. The company's paid-up capital increased to approximately ₹177.40 Crore after this issuance.
Dabur India has incorporated a new wholly owned step-down subsidiary, PRAVAAH CONSUMER GROUP INC., in Delaware, USA. This expansion strengthens its international footprint.
Dabur Q4 FY26 results show consolidated revenue growth of 7.3%, driven by double-digit performance in HPC and Home Care, despite headwinds in Middle East.
Dabur India delivered a resilient Q4 FY26 with 7.3% consolidated revenue growth, though geopolitical headwinds in the Middle East are impacting the international business.
Dabur India's Board approved the re-appointment of Mr. Rajiv Mehrishi as Independent Director for five years and Mr. Saket Burman as Non-Executive Director. Additionally, Mr. Mukesh Hari Butani's second-term tenure was modified from five years to one year. These leadership decisions are subject to shareholder approval at the upcoming Annual General Meeting.
Dabur India Ltd recommended a final dividend of Rs. 5.50 per share (550%) for FY 2025-26. The company fixed July 17, 2026, as the record date, with the AGM scheduled for August 06, 2026. If approved, dividend payment will be completed by September 04, 2026.
Dabur India Ltd has approved the re-appointment of Mr. Rajiv Mehrishi as Non-Executive Independent Director for a second five-year term starting September 2026. Additionally, Mr. Saket Burman was re-appointed as Non-Executive Director. The Board also modified Mr. Mukesh Hari Butani's second term tenure to one year, concluding in December 2026.
Dabur India Limited submitted its quarterly Security Cover Certificate for the period ended March 31, 2026. The certificate is reported as 'Not-Applicable' for its unsecured Non-Convertible Debentures (ISIN: INE016A08021) as per SEBI regulations.
Dabur India reported a 16% surge in Q4 FY26 consolidated net profit to Rs 362 Crore, with revenue up 7.3% at Rs 3,038 Crore. The board recommended a final dividend of 550%. International business grew 2.5%, led by Sub-Saharan Africa and Bangladesh, while the India FMCG business posted 9.5% growth.
Dabur India Q4 FY26 results show steady revenue growth and margin expansion driven by HPC and healthcare segments.
Dabur India Ltd reported revenue from operations of ₹3,038 Cr (+7.3% YoY) and net profit of ₹362 Cr (+15.8% YoY) for Q4 FY26.
Dabur India Limited reported consolidated annual revenue of ₹13,192.57 Crore and net profit of ₹1,868.69 Crore for FY26. The Board recommended a final dividend of ₹5.50 per share (550%), aggregating ₹975.53 Crore. The company's 51st Annual General Meeting is scheduled for August 06, 2026.
Dabur India Limited's subsidiary, Dabur International Limited, is incorporating a new step-down subsidiary, Trustline Brands Inc., in Delaware, USA. The entity will handle FMCG sales and distribution with a share capital of USD 10,000 (approx. ₹0.10 Crore). The incorporation is expected to be completed tentatively by May 31, 2026.
Dabur India Limited announced that its shareholders approved the Scheme of Amalgamation with Sesa Care Private Limited in an NCLT-convened meeting held on May 02, 2026. The resolution was passed with a 99.99% majority. This marks a key regulatory milestone in the company's consolidation strategy.
Dabur India Limited announced that unsecured creditors unanimously approved the Scheme of Amalgamation with Sesa Care Private Limited. The NCLT-convened meeting saw 100% of votes, representing ₹901.18 Crore in debt value, cast in favour of the resolution. This approval marks a key regulatory milestone in the merger process.
Dabur India Limited conducted meetings for its equity shareholders and unsecured creditors on May 02, 2026. The meetings, held via video conferencing, focused on approving the Scheme of Amalgamation between Sesa Care Private Limited and Dabur India Limited. The proceedings were conducted in compliance with NCLT orders and included remote e-voting facilities for stakeholders.
Dabur India Limited announced senior management changes following a board meeting. Mr. Rahul Sarawagi is appointed as Additional General Manager - IR & M&A effective April 28, 2026, while Ms. Isha Lamba has resigned from her position as Head-Investor Relations & M&A, effective May 2, 2026.